HIV/AIDS Related Conditions HIV and Mycobacterium Avium Complex (MAC) Common bacteria can be deadly in advanced HIV infection By Mark Cichocki, RN Mark Cichocki, RN LinkedIn Twitter Mark Cichocki, RN, is an HIV/AIDS nurse educator at the University of Michigan Health System for more than 20 years. Learn about our editorial process Updated on May 14, 2022 Medically reviewed by Latesha Elopre, MD, MSPH Medically reviewed by Latesha Elopre, MD, MSPH LinkedIn Latesha Elopre, MD, is a board-certified internist specializing in HIV and an assistant professor of infectious diseases at the University of Alabama at Birmingham. Learn about our Medical Expert Board Print Mycobacterium avium complex, also known as MAC, is a serious bacterial infection often seen in people with advanced HIV disease. While anyone can be infected with MAC, illness typically only presents in those with severely compromised immune systems. Sam Edwards/Getty Images As such, MAC is classified as an AIDS-defining illness, affecting anywhere from 20 percent to 40 percent of persons with AIDS-associated immune suppression who are not on HIV therapy or taking preventive prophylactic medications. MAC tends to most commonly affect the lungs, although many of these infections are not considered life-threatening. However, when a person's CD4 count drops below 50 cell/mL, MAC can move beyond the lungs and involve other major organ systems, including the liver, spleen, and bone marrow. It is then that MAC infection can become severe to life-threatening. Causes MAC organisms live all around us, including the soil, in foods, and in everyday livestock. MAC bacteria can be also found in many sources of drinking water, including treated water systems, and even in household dust. It is, therefore, very difficult to avoid. On the other hand, MAC does not seem to be passed from one person to person. Symptoms MAC infection often occurs in the lungs or intestines and can often present with few, if any, symptoms. However, when it spreads (disseminates) beyond the lungs and into the bloodstream, it can cause widespread infection. Early signs of disseminated MAC include: FeverNight sweatsChillsFatigue (often due to anemia)DiarrheaWeight loss (cachexia)Abdominal pain Diagnosis MAC disease is diagnosed by laboratory tests that can identify the MAC bacteria in samples of blood or bone marrow. Bone marrow samples are usually extracted from the hip bone with a needle, while blood samples are collected via a standard blood draw. The samples are then cultured in test tubes to determine whether the MAC bacteria is there or not. This takes around seven days. A computed tomography (CT) scan, which uses X-ray to create three-dimensional "slices" of your body, can be used to check for problems with your lymph nodes, liver, or spleen. Treatment MAC disease is most commonly treated with a combination of clarithromycin and ethambutol, with or without rifabutin. ART would also be initiated for those not yet on therapy. However, in persons with very low CD4 counts, there is a chance that MAC symptoms may flare up once ART is started. This is a phenomenon known as immune reconstitution inflammatory syndrome (IRIS), in which the compromised immune system is suddenly over-activated, causing an all-body inflammatory response. If this occurs, corticosteroids can be prescribed to treat the IRIS-associated symptoms until the immune response normalizes. Once the person's CD4 count is over 100 cells/mL and stabilizes above this level for six months, prophylactic treatment can be stopped. Prevention Since the avoidance of MAC is difficult to unlikely, the best way to avoid disease is to ensure that your immune system remains intact. This is best accomplished by treating HIV infection with antiretroviral therapy (ART). The use of ART can not only ensure your immune system remains strong, maintaining higher CD4 counts, but it can also restore immune function even in persons with moderate to severe immune suppression. Currently, ART is recommended for all individuals with HIV at the time of diagnosis. Early diagnosis and treatment will not only greatly prevent MAC and other opportunistic infections, but it is also associated with longer life and fewer HIV- and non-HIV-related illnesses. Sources Verywell Health uses only high-quality sources, including peer-reviewed studies, to support the facts within our articles. Read our editorial process to learn more about how we fact-check and keep our content accurate, reliable, and trustworthy. Johnson, J.; Driscoll, M.; Cohen, M. et al. Mycobacterium avium-Intracellulare Complex (MAC) Producing a Periportal Pseudotumor in a Patient With HIV and a Normal CD4 Count. ACG Case Rep J. 2017;3(4):e92. DOI: 10.14309/crj.2016.65. National Institutes of Health (NIH). Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents -Disseminated Mycobacterium Avium Complex Disease. Bethesda, Maryland; updated May 17, 2013. NIH. Starting Antiretroviral Therapy Early Improves Outcomes for HIV-infected Individuals. Bethesda, Maryland; issued May 27, 2015. U.S. Preventive Services Task Force (USPSTF). Screening for HIV: U.S. Preventive Services Task Force Recommendation Statement. Rockville, Maryland; April 2013. By Mark Cichocki, RN Mark Cichocki, RN, is an HIV/AIDS nurse educator at the University of Michigan Health System for more than 20 years. See Our Editorial Process Meet Our Medical Expert Board Share Feedback Was this page helpful? Thanks for your feedback! What is your feedback? Other Helpful Report an Error Submit